Stock Analysis
- United States
- /
- Medical Equipment
- /
- NasdaqGS:ALGN
Align Technology Second Quarter 2024 Earnings: Misses Expectations
Align Technology (NASDAQ:ALGN) Second Quarter 2024 Results
Key Financial Results
- Revenue: US$1.03b (up 2.6% from 2Q 2023).
- Net income: US$96.6m (down 14% from 2Q 2023).
- Profit margin: 9.4% (down from 11% in 2Q 2023). The decrease in margin was driven by higher expenses.
- EPS: US$1.28 (down from US$1.46 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Align Technology Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 1.2%. Earnings per share (EPS) also missed analyst estimates by 31%.
Looking ahead, revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US.
Performance of the American Medical Equipment industry.
The company's shares are down 10% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Align Technology's balance sheet and an in-depth analysis of the company's financial position.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:ALGN
Align Technology
Designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally.